Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5).

Obes Sci Pract · 2019 · PMC6469338 · PMID 31019730

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

on the borderline of significancep = 0.053so close (0.05 < p ≤ 0.1)

HbA1c remained a significant predictor in the liraglutide group ( p = 0.013) and on the borderline of significance when evaluated versus placebo ( p = 0.053), adjusting for sagittal abdominal diameter.

also in 75 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.